These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22067583)

  • 1. Tuberculosis and infection control.
    Karim K
    Br J Nurs; 2011 Sep 22-Oct 13; 20(17):1128, 1130-3. PubMed ID: 22067583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and acceptability of patient-specific infection control measures for pulmonary tuberculosis.
    Gonzalez-Angulo Y; Geldenhuys H; Van As D; Buckerfield N; Shea J; Mahomed H; Hanekom W; Hatherill M
    Am J Infect Control; 2013 Aug; 41(8):717-22. PubMed ID: 23375576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.
    Loveday M; Cox H; Evans D; Furin J; Ndjeka N; Osman M; Naidoo For The National Tb Think Tank 'Optimising Tb Treatment Outcomes' Task Team K
    S Afr Med J; 2020 Nov; 110(12):1160-1167. PubMed ID: 33403958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
    Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis.
    Hannan MM; Azadian BS; Gazzard BG; Hawkins DA; Hoffman PN
    J Hosp Infect; 2000 Jan; 44(1):5-11. PubMed ID: 10633047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance from WHO on the prevention and control of TB during air travel.
    Martinez L; Thomas K; Figueroa J
    Travel Med Infect Dis; 2010 Mar; 8(2):84-9. PubMed ID: 20478515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of tuberculosis infection control measures at HIV care and treatment sites in sub-Saharan Africa.
    Reid MJ; Saito S; Nash D; Scardigli A; Casalini C; Howard AA
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1605-12. PubMed ID: 23131257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special report. The new TB epidemic hits hospitals: causes, transmission, precautions.
    Hosp Secur Saf Manage; 1992 May; 13(1):5-9. PubMed ID: 10128719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection control to prevent tuberculosis in relation to resistance to antibiotics].
    Heltberg O; Holt J; Hilberg O
    Ugeskr Laeger; 2011 Mar; 173(12):880-3. PubMed ID: 21419056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis into the 2010s: is the glass half full?
    Ralph AP; Anstey NM; Kelly PM
    Clin Infect Dis; 2009 Aug; 49(4):574-83. PubMed ID: 19583517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia.
    Morozova I; Riekstina V; Sture G; Wells C; Leimane V
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):903-6. PubMed ID: 12971677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.